Mylan says FDA approves its generic multiple sclerosis treatment

(Reuters) - Mylan NV said the U.S. Food and Drug Administration has approved two doses of its generic version of Teva's Copaxone used to treat patients with relapsing forms of multiple sclerosis.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news